Efficacy of Jianpi Huatan Dingxuan Decoction in the Treatment of Vertigo and Phlegm Obstruction Syndrome

Objective: To explore the clinical effect of the application of Jianpi Huatan Dingxuan Decoction in the treatment of patients with vertigo and phlegm obstruction. Method: The research work was started in Henan Provincial Hospital of Traditional Chinese Medicine. The work will be carried out from October 2019 to October 2020. The patients are all patients with vertigo and phlegm obstruction syndrome who received treatment during this period. 100 of them were selected as this time. The study subjects were randomly divided into two groups, the control group given conventional western medicine treatment and the experimental group given Jianpi Huatan Dingxuan Decoction. The treatment effects of the two groups were compared and analyzed. Results: The treatment efficiency and nursing satisfaction of the experimental group were 96.00% and 94.00% respectively, which were significantly higher than the 82.00% and 78.00% of the control group. Before treatment, the vertebrobasilar blood flow velocity of the patients was relatively low, P>0.05. After the treatment intervention, the vertebral artery blood flow velocity and the basilar artery blood flow velocity of the experimental group were significantly higher than those of the control group. The data differed greatly. P<0.05, the experimental group had better results. Conclusion: The application of Jianpi Huatan Dingxuan Decoction in the treatment of patients with vertigo and phlegm obstruction has a significant effect, which can promote the recovery of patients, improve the effective rate of clinical treatment, and has positive significance for clinical development.

Download Full-text

Research on Association between Levels of Serum Adiponectin, Hs-CRP, and sICAM-1 and Hypertensive Cerebrovascular Complications

BioMed Research International ◽

10.1155/2021/4455038 ◽

2021 ◽

Vol 2021 ◽

pp. 1-7

Author(s):

Haijun Niu ◽

Rongyan Jiang ◽

Songwu Dong ◽

Linhu Xia ◽

Hongyi Fang

Keyword(s):

Blood Pressure ◽

Blood Flow ◽

Cerebrovascular Disease ◽

Flow Velocity ◽

Blood Flow Velocity ◽

Density Lipoprotein ◽

Control Group ◽

Cerebrovascular Complications ◽

Hs Crp ◽

Experimental Group

The study is aimed at studying the association between the levels of serum adiponectin (ADPN), high-sensitivity C-reactive protein (hs-CRP), and soluble intercellular adhesion molecule-1 (sICAM-1) and hypertensive cerebrovascular complications. 50 patients with hypertensive cerebrovascular disease treated in Gansu Provincial Hospital from December 2016 to December 2018 were selected as the experimental group, and 50 normal people who underwent physical examination were selected as the control group. The blood pressure, heart rate, and the complications were recorded, and the serum blood lipid indexes were detected. Moreover, the content of serum ADPN, hs-CRP, and sICAM-1; the neurological indexes; brain-derived neurotrophic factor (BNDF); and neurone-specific enolase (NSE) were also determined using ELISA. The content of aspartate aminotransferase (AST), alanine aminotransferase (ALT), blood urea nitrogen (BUN), and serum creatinine (SCR) in the experimental group was significantly higher than that in control group ( p < 0.05 ); the incidence of cerebrovascular complications, systolic blood pressure, diastolic blood pressure, and heart rate increased ( p < 0.05 ); the content of total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL), high-density lipoprotein (HDL), hs-CRP, and sICAM-1 obviously rose ( p < 0.05 ); and the content of ADPN and HDL obviously declined ( p < 0.05 ). Besides, the experimental group had evidently lower systolic blood flow velocity (Vs), diastolic blood flow velocity (Vd), and mean blood flow velocity (Vm) and evidently higher pulsatility index (PI) ( p < 0.05 ). The levels of S100 and NSE in the experimental group increased significantly, and the level of BNDF decreased significantly ( p < 0.05 ). In patients with hypertensive cerebrovascular disease, the level of ADPN declines; the levels of hs-CRP and sICAM-1 rise; the incidence rate of cerebrovascular complications is elevated; and there are changes in the blood lipid, cerebrovascular hemodynamic, and neurological indexes, thereby further promoting the occurrence and development of hypertensive cerebrovascular disease.

Download Full-text